Gene Expression Patterns Associated with Survival in Glioblastoma

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis.
• Accurate prognostic markers are crucial for personalized treatment strategies in GBM patients.

Purpose of the Study:

• To identify gene expression alterations associated with overall survival (OS) in glioblastoma.
• To develop and validate a novel mRNA-based prognostic index for GBM.

Main Methods:

• Gene expression profiling using the Nanostring nCounter platform.
• Identification of four significant genes (COL1A2, IGFBP3, NGFR, WIF1) differentiating GBM from normal brain tissue.
• Development of a Glioblastoma Prognostic Index (GPI) using a multivariate Cox model including age, extent of resection, and MGMT promoter methylation.

Main Results:

• The GPI score showed an inverse correlation with patient survival in both discovery and validation cohorts (TCGA).
• High GPI scores were associated with significantly shorter median OS (7.5 months discovery, 10.5 months validation).
• Low GPI scores were associated with significantly longer median OS (20.1 months discovery, 16.9 months validation).

Conclusions:

• The novel mRNA-based GPI is a valuable tool for classifying GBM patients into distinct risk groups.
• The GPI can refine prognosis estimates, potentially improving treatment decisions and clinical trial stratification for glioblastoma.